Global Biochips Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

A biochip market is a miniaturized laboratories or microarrays that perform thousands of simultaneous biochemical reactions. Biochips are used to perform multiple tests and enable to achieve higher output and speed. The Market is driven by significant demand in personalized medicine and drug discovery & development due to faster test results and accuracy. Growth & demand of Diagnostic market is boosting the global market. Technological advancement and adoption of automation techniques are creating huge scope for biochips market due to faster results and enhanced efficiency of biochips products. Biochips contain very micro sensors which enable to perform speedier test in short period of time.

Biochips technology is boosted by the growth and advancement of proteomics & genomics market. Additionally, rising life style-oriented diseases such as CVD, CHD, Cancer, Diabetes and other lingering diseases are boosting the biochips market. Certain restraints such as high costs of biochips and stringent government regulations are still some of the major concerns hindering the market. However, various other factors such as Research & Development in human genome project which enable to explore DNA sequencing through biochips is expected to drive the future market growth.

Related Reports: Medical Devices Industry

North America has the highest contribution to Global Biochips Market followed by Europe due to significant adoption of Biochips in hospitals, research centers and academic institutes. North America is contributing nearly half of the total market share due to huge adoption of Biochips applications and huge investment in Biochips market. APAC countries such as China, India, Japan and Korea are expected to create huge opportunity for global Biochips market due to huge demand of Biochips application for diagnostics. APAC region is predicted to be a lucrative region due to rising lifestyle-oriented diseases, increase in adoption of biochips in research institutes and hospitals and improved healthcare spending.

The Key players of Global Biochips market include Abbott Laboratories, Bio-Rad Laboratories Inc., Cepheid Inc., Epigem Ltd, GE Healthcare, Illumina, Inc., Lifesensors, Roche Diagnostics, Thermo Fisher Scientific, Inc. and others. R&D, Partnership, product launch and Collaboration are the key winning strategies adopted by Market players across the globe.

Market Segmentation

Global Biochips Market is segmented on the basis of type, fabrication, end user and region. Global Biochips Market by type includes DNA chips market; Lab on Chips and Protein Chips. Global Biochips Market by Fabrication technology includes Microarrays, Micro fluidics market. Global Biochips Market by end user includes Hospitals, Diagnostic centers, Research Institutes, Academic Institutes and other end users.

• Global Biochips Market Research and Analysis, By Type
• Global Biochips Market Research and Analysis, By Fabrication Technology
• Global Biochips Market Research and Analysis, By End-users

Browse full report @ https://www.omrglobal.com/industry-reports/biochips-market/

CONTACT US

India: +91-780-304-0404
Global: +1-646-755-7667
Email: info@omrglobal.com
Website: www.omrglobal.com